November 15th 2024
The algal EPA+DHA ingredient expands on the company's existing algal omega-3 portfolio which was DHA only.
FrieslandCampina Ingredients launches plant-derived LCPUFA infant milk formula ingredients
November 25th 2022FrieslandCampina Ingredients extended its Vana-Sana range of micro-encapsulated long-chain polyunsaturated fatty acid (LCPUFA) ingredients for infant milk formula (IMF) with three new fish-oil-free launches.
FDA sends warning letters to dietary supplement companies claiming to treat cardiovascular disease
November 18th 2022On November 17, the agency sent warning letters to Essential Elements, Calroy Health Sciences, Iwi, BergaMet North America, Healthy Trends Worldwide, Chambers’ Apothecary, and Anabolic Laboratories.
Combination of black seed oil and omega-3 supports gut and immune health in athletes
October 25th 2022Results showed that compared to placebo, subjects taking the combination of black seed oil and omega-3s saw significantly fewer upper-respiratory tract complaints and better overall well-being, as well as higher omega-3 blood levels, lower cortisol levels, and superior microbiome indices.
ISSFAL issues statement on relationship between omega-3 blood levels and preterm birth risk
October 4th 2022The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has issued a statement acknowledging the relationship between omega-3 EPA and DHA blood levels and preterm birth risk.
Aker BioMarine signs license and supply agreement for Lysoveta with Trofi Nutritionals
September 2nd 2022As part of the agreement, Aker BioMarine will license and supply Lysoveta to Trofi, who will invest in clinical trials with the aim to develop and commercialize certain medical foods within the fields.